Toddler Infected With Rare Side Effect Of Smallpox Vaccination Recovering

...r. Kahana recalled. The doctors worked with the Food and Drug Administration to allow the use of an experimental drug for smallpox, ST-246, from siga Technologies, which appeared to begin turning the case around. Meanwhile, doctors drained the boys distended abdomen and cut away the dead skin,...

Immune function could benefit from exercise

...etermine the role of stress on immune function, was tested before training and at 4 and 12 months after training. Researchers found that the levels of siga increased with exercise and as the time of exercise increased, so, too, did the levels of SIgA. The researchers thus concluded that regular moderate e...

SIGA in Medical Technology

Albemarle Optimizes Smallpox Drug Candidate for SIGA

Fine Chemistry Services unit demonstrates pilot production for "fast track" drug BATON ROUGE, La., May 5 /PRNewswire-FirstCall/ -- Two American companies are teaming up for second-round test-phase production of a FDA-designated "fast track" drug candidate to trea...

SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193

... NEW YORK--(BUSINESS WIRE)--May 15, 2007 - siga Technologies, Inc. (NASDAQ: SIGA) announced today ... what is seen in human Lassa fever infections, and siga expects that this model is one of the two animal m...National Institutes of Health (NIH), which awarded siga a $6.0 million grant in September 2006. About...

SIGA in Biological Technology

Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthene's Legal Action in Breach of Contract Lawsuit Against SIGA

ANNAPOLIS, Md., Jan. 16 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced that the Delaware Chancery Court today issued a ruling denying a motion by SIGA Technologies to dismiss ...

Alliance for Biosecurity Testifies Before Congress on Funding for Medical Countermeasure Development

...utics, Emergent BioSolutions, Hematech, Inc., a subsidiary of Kyowa Kirin, Human Genome Sciences, Inc., NanoViricides, Inc., Pfizer Inc., PharmAthene, siga Technologies, and Unither Virology LLC, a subsidiary of United Therapeutics. ...

Department of Health & Human Services Names Dr. Eric Rose to National Biodefense Science Board

...ces, who also serves as Chief Executive Officer of siga Technologies, Inc., has been named to the National...ent Services, Scientific Games, Harland Clarke and siga Technologies. About SIGA siga Technologies is applying viral and bacterial genom...

HHS Secretary Leavitt Announces Members of the National Biodefense Science Board

...er for numerous journals. Eric A. Rose, M.D. Dr. Rose is executive vice president for life sciences at MacAndrews & Forbes Holdings and CEO of siga Technologies, Inc. He is currently on leave as professor and chairman of the Department of Surgery at Columbia University College of Physicians and Su...